29
Participants
Start Date
April 22, 2022
Primary Completion Date
April 4, 2025
Study Completion Date
June 30, 2025
Hyperbaric oxygen
The treatment consists of exposure to hyperbaric oxygen at 2.5 atmospheric absolutes (ATA) for a total of 90 minutes after compression to 2.5 atmosphere absolutes (ATA) in a monoplace hyperbaric chamber breathing 100% oxygen. The subjects will be in the chamber for a total of 120 minutes as approximately 10-15 minutes are spent during the compression and decompression phases and subjects have 5-10 minute room air breaks every 30 minutes of hyperbaric oxygen treatment.
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester
National Cancer Institute (NCI)
NIH
University of Rochester
OTHER